Vertex, CRISPR Therapeutics’ blood disorder gene therapy shows more promise
CTX001 is being evaluated as a one-time treatment for transfusion dependent beta thalassemia and sickle cell disease
Read More
Tag: CRISPR
Horizon enlists Mammoth in CRISPR move
The San Fransisco-based biotech built the first CRISPR-based detection platform for diagnostics.
Read More
GSK, Uni of California pair up to advance genomic research
The LGR will receive up to $67 million in funding over a five-year period.
Read More
Oxford Genetics wins six licensing deals
Oxford Genetics has won six new licensing deals for its scalable gene therapy manufacturing technologies.
Read More
Genome editing successful in correcting muscular dystrophy in mice
Researchers at Duke University have shown that CRISPR genome editing technology can safely and stably correct Duchenne muscular dystrophy in mice.
Read More
Cancer Research and AstraZeneca launch genomics centre
Cancer Research UK and AstraZeneca have announced that they are opening a new centre in Cambridge, UK, dedicated to realising the full potential of functional genomics in the discovery and development of new drugs for patients with cancer.
Read More
Allergan signs up to Editas’ genome editing tech
Allergan has secured itself exclusive access to Editas Medicine’s genome-editing ocular programmes under a strategic research and development pact between the two firms.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
